Press release
New radiation therapy treatment arrives at KHCC
Radiation therapy is one of the primary weapons used to fight cancer in modern medicine. Since January 1st 2010, the King Hussein Cancer Centre has begun using a new form of radiation therapy known as IMRT – Intensity Modulated Radiation Therapy. This new technique represents the very latest in medical technology to arrive at the KHCC Radiation Oncology Department, where it is currently being used to successfully treat a range of conditions.Radiation therapy works by delivering precise doses of radiation to cancerous tumours within the body, with the aim of destroying the tumour’s cells. Doses are usually given through beams directed at the tumour from different angles via a machine, called a linear accelerator – Linac for short. Although effective, radiation therapy often damages healthy body cells as well as cancerous ones since the beams will inevitably hit the tissues and organs surrounding the tumour. However, IMRT works by varying the intensity of the radiation doses, minimising the damage to healthy cells and lessening the side effects of the treatment.
IMRT also makes advances in the planning stage of the treatment. With older forms of radiation therapy hospital physicists would test a number of different beam intensities and angles before the correct dose is given to the patient. With IMRT, physicists attempt the opposite; they decide in advance how much radiation the tumour is to be given. They then feed these numbers into a computer running an inverse IMRT software, which then calculates the appropriate intensities of radiation to be given to the patient as the beam passes over the tumour.
All this adds up to a much safer and less painful experience for many of KHCC’s patients. According to Dr Al Mousa, Chairman of the Department of Radiation Oncology at KHCC, IMRT is very much the way forward:
“It’s an updated form of 3D radiation therapy, but more precise. It saves the normal tissue and decreases the side affects of the treatment. There has also been evidence-based literature that shows the benefits of IMRT, although randomised trials have yet to be carried out. By modulating the intensity of the radiation we can target the tumour more accurately, and reduce the side effects for the patient. For example, patients with tumours in the head or neck often suffer from an acutely dry mouth, after radiation has destroyed the saliva glands. With IMRT, these symptoms are not as severe.”
Leila was a patient at KHCC who recently underwent IMRT, and is able to confirm its effectiveness. Leila came to KHCC for a check-up on the recommendation of her optometrist, after she experienced pain in her eye. A CT scan revealed a tiny tumour in her sinus. Following further tests, including an MRI and a biopsy, the doctors at KHCC decided to put Leila through the new IMRT machines, the first patient with a head tumour to do so
“My sessions lasted for a month, I had them every morning except for weekends. It was the first time I learnt to appreciate my weekends! I went into the room with all the technicians, and then lay down on the machine with my head fixed in place with a custom made mask. The experience is a little harsh, but the staff were amazing and talked me through every single aspect of the treatment. After the treatment I experienced some dryness in my mouth, but not aside from that I felt OK. With my type of treatment there is a risk of fungal infection, but I didn’t experience that at all.”
According to Dr Al Mousa, the new IMRT technique saved Leila a great deal of pain:
“With previous types of radiation therapy treatment to the head or neck would lead to a much more severe symptoms. Patients are often unable to talk for a period of time following treatment. In Leila’s case, no such symptoms occurred and she is doing very well.”
IMRT is a vital advance in medical technology, and it has shown itself to be a highly effective means of treating cancer more efficiently, and with less risk to the patient. KHCC’s use of the new technology ensures the centre remains well equipped to help its patients the very best it can.
The King Hussein Cancer Center (KHCC) is the only specialized cancer center in the Middle East that treats both adult and pediatric patients. Founded in 1997, KHCC is a non-governmental, not-for-profit comprehensive center dedicated entirely to cancer care. It has achieved several international and national recognitions
King Hussein Cancer Center
P.O.BOX 1269 Al-Jubeiha Amman 11941 Jordan
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release New radiation therapy treatment arrives at KHCC here
News-ID: 168384 • Views: …
More Releases from King Hussein Cancer Center

Sentinel Lymph Node Dissection
Health care professionals at the King Hussein Cancer Center (KHCC) work tirelessly not only to treat cancer, but to treat the patient with cancer. Doctors are trained in the latest available techniques and findings; employ the most recent proven methods of diagnosis, procedures and treatment; and utilize state-of-the-art medical equipment. KHCC care is patient centric, focusing on the best interests of the patient-aggressively attacking cancer while working to minimize side…

Jordan Celebrates World Cancer Day 2011
Press Release – Amman - Monday February 8th 2011 – Jordan celebrates World Cancer Day (WCD) 2011 this February along with the global community. The King Hussein Cancer Center (KHCC), The World Health organization (WHO), and the Ministry of Health (MoH) of Jordan have come together to highlight the importance of cancer awareness and cancer control as a theme for the 2011 event.
The World Cancer Day is an…
More Releases for IMRT
[Latest] Intensity Modulated Radiotherapy Market Overview: Importance, Trends, a …
Intensity Modulated Radiotherapy Market: Outlook and Investment Analysis
Q1: What is the current market outlook for Intensity Modulated Radiotherapy (IMRT)?
The Intensity Modulated Radiotherapy market is experiencing robust growth driven by the rising prevalence of cancer worldwide and increasing demand for advanced, targeted cancer treatment options. IMRT offers precise radiation delivery, minimizing damage to surrounding healthy tissues, which significantly improves patient outcomes. Technological advancements, such as integration with imaging techniques and AI-based…
Rising Government Support and Demand for Non-Invasive Cancer Treatments Fuel Gro …
The global market for Intensity Modulated Radiotherapy (IMRT) was valued at USD 2.21 billion in 2022 and is projected to grow steadily at a compound annual growth rate (CAGR) of 5.4% over the coming years, according to a recent report by Emergen Research. This growth is largely driven by increasing government support for cancer management and a growing preference for non-invasive cancer treatments.
IMRT is a sophisticated technology that customizes radiation…
Intensity-modulated radiotherapy (IMRT) Market Trends, Key Players, DROT, Analys …
The global intensity-modulated radiotherapy (IMRT) market size was estimated at USD 2.1 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 5.2% from 2023 to 2032. The growth of this market is driven by several factors, including the increasing incidence of cancer, technological advancements in radiation therapy, and the rising demand for precise and personalized cancer treatment. Intensity-modulated radiotherapy, commonly referred to as…
Intensity Modulated Radiotherapy Market worth $3.32 billion by 2030, growing at …
The "Intensity Modulated Radiotherapy Market by Indication (Breast Cancer, Gastrointestinal Cancer, Gynecological Cancer), Radiation Type (Carbon-Ion Radiation, Electron Radiation, Photon Radiation), End-User - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering.
The Global Intensity Modulated Radiotherapy Market to grow from USD 2.30 billion in 2023 to USD 3.32 billion by 2030, at a CAGR of 5.36%.
Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/intensity-modulated-radiotherapy?utm_source=openpr&utm_medium=referral&utm_campaign=sample
The Intensity Modulated Radiotherapy (IMRT) constitutes a significant…
Intensity Modulated Radiotherapy Market stood USD 1.82 Bn in 2022, Projected CAG …
The global healthcare landscape has witnessed a profound surge in the demand for advanced cancer treatment options, notably in the realm of Intensity Modulated Radiotherapy (IMRT). TechSci Research's report, "Intensity Modulated Radiotherapy Market - Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028", has illuminated the robust standing of the Global Intensity Modulated Radiotherapy Market, which stood at USD 1.82 billion in 2022, and anticipates a steady growth trajectory…
Intensity-modulated Radiotherapy Market worth $2.8 billion by 2028
Intensity-modulated Radiotherapy Market in terms of revenue was estimated to be worth $2.2 billion in 2023 and is poised to reach $2.8 billion by 2028, growing at a CAGR of 5.2% from 2023 to 2028 according to a new report by MarketsandMarkets™. The expansion of the Intensity-modulated radiotherapy market is propelled by several synergistic factors, including robust healthcare infrastructure, escalating cancer prevalence, conducive reimbursement policies, technological innovations, active research initiatives,…